Rapid immunodot AQP4 assay for neuromyelitis optica spectrum disorder

Y Fu, J Bi, Y Yan, X Sun, K Li, SY Kim, SM Han… - JAMA …, 2023 - jamanetwork.com
Importance Immunoglobulin G autoantibodies for aquaporin 4 (AQP4-IgG) serve as
diagnostic biomarkers for neuromyelitis optica spectrum disorder (NMOSD), and the most …

Diagnostic value of aquaporin-4-IgG live cell based assay in neuromyelitis optica spectrum disorders

V Redenbaugh, M Montalvo, E Sechi… - Multiple Sclerosis …, 2021 - journals.sagepub.com
Objective Determine the utility of aquaporin 4 IgG (AQP4-IgG) testing (live cell-based assay)
for Neuromyelitis Optica Spectrum Disorders (NMOSD). Methods We included Mayo Clinic …

[PDF][PDF] Large-scale in-house cell-based assay for evaluating the serostatus in patients with neuromyelitis optica spectrum disorder based on new diagnostic criteria

Y Kim, G Kim, BS Kong, JE Lee… - Journal of Clinical …, 2017 - synapse.koreamed.org
Background and Purpose The detection of aquaporin 4-IgG (AQP4-IgG) is now a critical
diagnostic criterion for neuromyelitis optica spectrum disorder (NMOSD). To evaluate the …

[HTML][HTML] Clinical usefulness of cell-based indirect immunofluorescence assay for the detection of aquaporin-4 antibodies in neuromyelitis optica spectrum disorder

E Kang, JH Min, KH Lee, BJ Kim - Annals of laboratory …, 2012 - synapse.koreamed.org
Background The presence of antibodies to aquaporin-4 (AQP4) has been identified as a key
characteristic of neuromyelitis optica spectrum disorder (NMOSD), an autoimmune …

Updated estimate of AQP4-IgG serostatus and disability outcome in neuromyelitis optica

Y Jiao, JP Fryer, VA Lennon, SM Jenkins, AML Quek… - Neurology, 2013 - AAN Enterprises
Objective: To 1) determine, using contemporary recombinant antigen–based assays, the
aquaporin-4 (AQP4)–immunoglobulin G (IgG) detection rate in sequential sera of patients …

Factors associated with the misdiagnosis of neuromyelitis optica spectrum disorder

AD Smith, TM Moog, KW Burgess, M McCreary… - Multiple Sclerosis and …, 2023 - Elsevier
Background Neuromyelitis optica spectrum disorder (NMOSD) is a rare autoimmune
condition that is associated with severe disability. Approximately 40% of individuals are …

[HTML][HTML] Serum aquaporin 4-immunoglobulin G titer and neuromyelitis optica spectrum disorder activity and severity: a systematic review and meta-analysis

J Liu, G Tan, B Li, J Zhang, Y Gao, Y Cao, Z Jia… - Frontiers in …, 2021 - frontiersin.org
Background: Aquaporin 4-immunoglobulin G (AQP4-IgG) plays a major role in the
pathogenesis of neuromyelitis optica spectrum disorder (NMOSD). Seropositive status for …

[HTML][HTML] Accuracy of the fluorescence-activated cell sorting assay for the aquaporin-4 antibody (AQP4-Ab): comparison with the commercial AQP4-Ab assay kit

J Yang, SM Kim, YJ Kim, SY Cheon, B Kim, KC Jung… - PLoS …, 2016 - journals.plos.org
Background The aquaporin-4 antibody (AQP4-Ab) is a disease-specific autoantibody to
neuromyelitis optica (NMO). We aimed to evaluate the accuracy of the FACS assay in …

AQP4 autoantibody assay performance in clinical laboratory service

JP Fryer, VA Lennon, SJ Pittock… - Neuroimmunology & …, 2014 - AAN Enterprises
Objective: To compare performance of contemporary aquaporin-4–immunoglobulin (Ig) G
assays in clinical service. Methods: Sera from neurologic patients (4 groups) and controls …

[HTML][HTML] Aquaporin-4 autoantibodies in neuromyelitis optica spectrum disorders: comparison between tissue-based and cell-based indirect immunofluorescence …

KH Chan, JSC Kwan, PWL Ho, JWM Ho… - Journal of …, 2010 - Springer
Background Neuromyelitis optica spectrum disorders (NMOSD) are severe central nervous
system inflammatory demyelinating disorders (CNS IDD) characterized by monophasic or …